Celltrion Selects Movilitas for Serialization and Traceability Implementations to Ensure Supply Chain Integrity and Compliance
AsiaNet 84940
COLUMBIA, Maryland, July 29, 2020 /PRNewswire=KYODO JBN/ --
-- Project delivers a combined solution for end-to-end visibility in EU, Korea
and U.S. markets
Movilitas, a technology leader delivering the next generation of solutions and
consulting services across multiple industries to advance smart supply chain
ecosystems, announced today that Celltrion, a global leading biopharmaceutical
company, selected Movilitas to manage their SAP(R) Advanced Track and Trace for
Pharmaceuticals (ATTP) and SAP Information Collaboration Hub (ICH) deployments.
This digital transformation creates a foundation that addresses all
requirements for serialization compliance, traceability and country reporting
in the EU, Korea and U.S. regions.
Logo - https://mma.prnewswire.com/media/1011119/Movilitas_Logo.jpg
Celltrion selected Movilitas for its full set of SAP solution services and
accelerators in order to address compliance with the EU, Korea and U.S.
serialization requirements. Movilitas' integrator services plus industry
expertise with multiple country serialization regulations enabled Celltrion's
successful SAP implementation. Additionally, Movilitas offered a hybrid project
delivery system of onsite and remote, including a native speaker stationed in
Korea. This combination of experience and flexibility allowed Celltrion and
Movilitas to complete the integration process within two months.
"At Celltrion, we understand that end-to-end traceability provides safe and
effective products for patients as well as a more efficient and resilient
supply chain. The combination of Movilitas' experience and industry knowledge
has helped Celltrion stay at the front with traceability solutions that
future-proof our operations and protect consumers," said Joon Serk Seo,
Director, Celltrion.
"The combined solution enables Celltrion to meet a common pharmaceuticals
industry challenge of ensuring supply chain integrity for its products.
Serialization and traceability technologies play a critical role in enabling
pharmaceutical protection," said Ross Young, CEO of Movilitas. "We are pleased
that Celltrion was able to take advantage of Movilitas integration services and
our efficient and flexible delivery model to ensure compliance in their key
markets."
About Celltrion
Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical
company, specializing in research, development and manufacturing of biosimilar
and innovative drugs. Celltrion strives to provide more affordable biosimilar
mAbs to patients who previously had limited access to advanced therapeutics.
Celltrion received FDA and EC's approval for Inflectra(R) and Remsima(R),
respectively, which is the world's first mAb biosimilar to receive approval
from a regulatory agency in a developed country. For more information, visit:
About Movilitas
Movilitas is a technology leader delivering the next generation of solutions
and consulting services across multiple industries to advance smart supply
chain ecosystems. We are recognized as a trusted SAP partner for digital supply
chain transformation. We help businesses realize new growth opportunities,
adapt to today's on-demand economy and maintain compliance. Through services,
such as Movilitas.Cloud, or extensions and accelerators for SAP solutions, our
clients unlock data to realize greater efficiencies and new revenue streams.
For more information, visit movilitas.com (
), or LinkedIn (
), Twitter (
) or Xing (
).
SOURCE Movilitas
CONTACT: Amy Platt, +1-571-299-8087, amy.platt@movilitas.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
